Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03906071
Other study ID # 516-005
Secondary ID
Status Active, not recruiting
Phase Phase 3
First received
Last updated
Start date July 15, 2019
Est. completion date April 30, 2024

Study information

Verified date October 2023
Source Mirati Therapeutics Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will compare the efficacy of the investigational agent sitravatinib in combination with nivolumab versus docetaxel in patients with advanced non-squamous NSCLC who have previously experienced disease progression on or after platinum-based chemotherapy and checkpoint inhibitor therapy.


Description:

Sitravatinib (MGCD516) is an orally-available, small molecule inhibitor of a closely related spectrum of receptor tyrosine kinases (RTKs) including MET, TAM (Tyro3, AXL, MERTK) family, VEGFR family, PDGFR family, KIT, FLT3, TRK family, RET, DDR2, and selected EPH family members. Nivolumab is a human IgG monoclonal antibody that binds to the PD-1 receptor and selectively blocks the interaction with its ligands PD-L1 and PD-L2, thereby releasing PD-1 pathway mediated inhibition of the immune response, including anti-tumor immune response. RTKs have been implicated in mediating an immunosuppressive tumor microenvironment, which has emerged as a potential resistance mechanism to checkpoint inhibitor therapy. Inhibition of these RTKs by sitravatinib may augment anti-tumor immune response and improve outcomes by overcoming resistance to checkpoint inhibitor therapy.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 532
Est. completion date April 30, 2024
Est. primary completion date March 20, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Diagnosis of Non-Squamous Non-Small Cell Lung Cancer - Receipt of at least one but not more than two prior treatment regimens in the advanced setting - Prior treatment with PD-1/PD-L1 checkpoint inhibitor therapy and platinum-based chemotherapy in combination or in sequence (i.e., platinum-based chemotheraphy followed by checkpoint inhibitor therapy) - Most recent treatment regimen must have included a checkpoint inhibitor therapy with radiographic disease progression on or after treatment - Candidate to receive docetaxel as second or third line therapy Exclusion Criteria: - Uncontrolled brain metastases - Tumors that have tested positive for EGFR, ROS1, ALK mutations, or ALK fusions - Unacceptable toxicity with prior checkpoint inhibitor therapy - Receipt of systemic anti-cancer therapy post checkpoint inhibitor therapy, other than maintenance chemotherapy - Impaired heart function

Study Design


Related Conditions & MeSH terms


Intervention

Biological:
Nivolumab
Nivolumab is an antibody directed at the programmed death receptor-1 (PD-1), blocking its interaction with PD-L1 and PD-L2.
Drug:
Sitravatinib
Sitravatinib is a small molecule inhibitor of receptor tyrosine kinases.
Docetaxel
Docetaxel is an anti-neoplastic agent that acts by disrupting the microtubular network in cells.

Locations

Country Name City State
Belgium Algemeen Ziekenhuis Klina Brasschaat Antwerp
Belgium Grand Hôpital de Charleroi - Notre Dame Charleroi Henegouwen
Belgium Universitair Ziekenhuis Antwerpen Edegem
Belgium Algemeen Ziekenhuis Maria Middelares Gent Oost-Vlaaderen
Belgium Universitair Ziekenhuis Gent Gent
Belgium Algemeen Ziekenhuis Delta Roeselare West-Vlaanderen
Belgium Algemeen Ziekenhuis Glorieux Ronse Ronse East Flanders
Belgium Centre Hospitalier Universitaire Universite Catholique de Louvain - Site Godinne Yvoir Namur
Canada Tom Baker Cancer Centre Calgary Alberta
Canada Juravinski Cancer Centre Hamilton Ontario
Canada Horizon Health Network - The Moncton Hospital Moncton New Brunswick
Canada Institut Universitaire de Cardiologie et de Pneumologie de Québec-Universite Laval Québec
Canada Saint John Regional Hospital Saint John New Brunswick
Canada Saskatoon Cancer Center Saskatoon
Canada Princess Margaret Cancer Centre Toronto Ontario
Canada Windsor Regional Hospital Cancer Program Windsor Ontario
France Hôpital Morvan Brest
France Hôpital Louis Pradel Bron
France Centre Hospitalier Intercommunal de Créteil Créteil
France Centre Georges François Leclerc Dijon Cedex
France Centre Hospitalier Le Mans Le Mans Cedex 9
France Centre Hospitalier Universitaire Limoges Limoges Cedex
France Centre Léon Bérard Lyon
France Institut Paoli-Calmettes Marseille
France Hôpital Nord de Marseille Marseille cedex 20
France Institut Régional du Cancer de Montpellier - Val d'Aurelle Montpellier
France Hôpital Bichat-Claude-Bernard Paris Cedex 18
France Rouen University Hôpital Charles-Nicolle Rouen
France Centre Hospitalier Universitaire De Nantes - Hôpital Nord Laennec Saint-Herblain
France Institut de Cancérologie Strasbourg Europe Strasbourg
France Institut Gustave Roussy Villejuif Cedex
Germany Evangelische Lungenklinik Berlin Berlin
Germany Universitätsklinikum Bonn Bonn
Germany KEM. Evang.Kliniken Essen-Mitte gGmbh Essen
Germany Asklepios Fachkliniken München-Gauting Gauting
Germany LungenClinic Grosshansdorf GmbH Großhansdorf Schleswig-Holstein
Germany Martha-Maria Krankenhaus Halle-Dölau gGmbH, Studiensekretariat Halle
Germany Klinik Löwenstein gGmbH Heilbronn Baden-Württemberg
Germany Klinikverbund Kempten-Oberallgäu - Klinik Immenstadt - Klinikverbund Allgäu gGmbH Immenstadt Bayern
Germany Klinikum Kassel Kassel
Germany Kliniken der Stadt Köln Köln
Germany Universitatsklinikum Schleswig-Holstein-Campus Lubeck Lübeck
Germany Universitätsmedizin der Johannes Gutenberg-Universität Mainz - III. Medizinischen Klinik und Poliklinik Mainz
Germany Klinikum rechts der Isar der Technischen Universität München München
Germany Munchen Klinik Bogenhausen München
Hungary Országos Korányi Tbc És Pulmonológiai Intézet Budapest
Hungary Országos Onkológiai Intézet Budapest
Hungary Semmelweis Egyetem - Pulmonológiai Klinika Budapest
Hungary Petz Aladár Megyei Oktató Kórház Gyor Gyor-Moson-Sopron
Hungary Intézeti Gyógyszertár Szombathely Vas
Hungary Szent Borbála Kórház Tatabánya Komárom-Esztergom
Hungary Törökbálinti Tüdogyógyintézet Törökbálint
Israel Emek Medical Center Afula
Israel Soroka Medical Center Be'er Sheva
Israel Shamir Medical Center (Assaf Harofeh) Be'er Ya'aqov
Israel Shaare Zedek Medical Center Jerusalem
Israel Chaim Sheba Medical Center Ramat Gan
Israel Ziv Medical Center Safed
Israel The Edith Wolfson Medical Center Tel Aviv
Italy Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo Alessandria
Italy IRCCS Istituto Tumori "Giovanni Paolo II" Bari
Italy Azienda Ospedaliero Universitaria Policlinico "G.Rodolico - San Marco" Catania
Italy Ospedale di Cremona Cremona
Italy ASL Lecce - Ospedale Vito Fazzi Lecce
Italy Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori Meldola Forlì-Cesena
Italy Istituto Europeo di Oncologia Milano Lombardia
Italy S.C Oncologia Medica, ASST Monza - Ospedale San Gerardo Monza
Italy Istituto Nazionale Tumori IRCCS Fondazione G. Pascale Napoli Naples
Italy Azienda Ospedaliero-Universitaria di Parma Parma
Italy Ospedale Guglielmo da Saliceto Piacenza
Italy Azienda Ospedaliero - Universitaria Pisana Pisa
Italy Istituto Nazionale Tumori Regina Elena Roma
Italy ASST-SETTE LAGHI, Ospedale di Circolo e Fondazione Macchi Varese
Netherlands Amsterdam Universitair Medische Centra - Vrije Universiteit Medisch Centrum Amsterdam
Netherlands The Netherlands Cancer Institute Amsterdam Noord-Holland
Netherlands Amphia Ziekenhuis - Breda Molengracht Breda
Netherlands Hagaziekenhuis Van Den Haag - Leyweg Den Haag Zuid-Holland
Netherlands Albert Schweitzer Ziekenhuis Dordrecht
Netherlands Martini Ziekenhuis Groningen
Netherlands Maastricht Universitair Medisch Centrum Maastricht Limburg
Netherlands Ziekenhuis Nieuwegein Nieuwegein Utrecht
Netherlands Radboud University Medical Center Nijmegen
Netherlands Erasmus Medisch Centrum Rotterdam Zuid-Holland
Netherlands Jeroen Bosch Ziekenhuis s-Hertogenbosch North Brabant
Netherlands Franciscus Vlietland & Gasthuis Schiedam South Holland
Netherlands UMC Utrecht Utrecht
Netherlands Isala Zwolle Overijssel
Spain Complejo Hospitalario Universitario A Coruña A Coruña La Coruña
Spain Institut Català d'Oncologia Badalona, Hospital Universitari Germans Trias i Puj Badalona Barcelona
Spain Hospital del Mar - Parc de Salut Mar Barcelona
Spain Hospital Universitari Dexeus Barcelona
Spain Hospital Universitario Vall d'Hebron Barcelona
Spain Complejo Hospitalario de Jaén Jaén
Spain Hospital Universitario Insular de Gran Canaria Las Palmas De Gran Canaria
Spain Hospital de León León
Spain Hospital Universitario Lucus Augusti Lugo
Spain Clinica Universidad de Navarra - Madrid Madrid
Spain Complejo Hospitalario Ruber Juan Bravo Madrid
Spain Hospital Clinico San Carlos Madrid
Spain Hospital Universitario 12 de Octubre Madrid
Spain Hospital Universitario Fundación Jiménez Díaz Madrid
Spain Hospital Universitario La Paz Madrid
Spain Hospital Universitario La Princesa Madrid
Spain Hospital Universitario Ramón y Cajal Madrid
Spain Hospital Universitario Puerta de Hierro - Majadahonda Majadahonda Madrid
Spain Hospital Regional Universitario de Málaga - Hospital Civil Málaga Malaga
Spain Hospital Universitario Central de Asturias Oviedo
Spain Hospital Clínico Universitario de Santiago de Compostela Santiago De Compostela A Coruña
Spain Fundacion Instituto Valenciano de Oncologia Valencia
Spain Hospital Universitari i Politècnic La Fe Valencia
Spain Hospital Alvaro Cunqueiro - Clinico Universitario Vigo Vigo
Switzerland HUG: hopitaux universitaires de genève Genève
Switzerland Centre Hospitalier Universitaire Vaudois Lausanne
Switzerland Kantonsspital Winterthur Winterthur
United Kingdom Velindre University NHS Trust Cardiff
United Kingdom University Hospitals of Leicester NHS Trust Leicester
United Kingdom Barts Health NHS Trust London
United Kingdom Royal Free London NHS Foundation Trust London
United Kingdom The Royal Marsden NHS Foundation Trust London
United Kingdom East and North Hertfordshire NHS Trust Northwood Middlesex
United Kingdom The Royal Marsden NHS Foundation Trust Sutton
United Kingdom Royal Cornwall Hospital NHS Trust Truro Cornwall
United Kingdom The Christie NHS Foundation Trust Withington Manchester
United States ThedaCare Regional Cancer Center Appleton Wisconsin
United States University Cancer and Blood Center - LLC - Athens Athens Georgia
United States Piedmont Cancer Institute Atlanta Georgia
United States Texas Oncology - South Austin Austin Texas
United States Comprehensive Blood and Cancer Center - Bakersfield Bakersfield California
United States Texas Oncology - Beaumont Mamie Mcfaddin Ward Cancer Center Beaumont Texas
United States Beverly Hills Cancer Center Beverly Hills California
United States St. Vincent Frontier Cancer Center Billings Montana
United States Alabama Oncology - Grandview Birmingham Alabama
United States Central Care Cancer Center - Bolivar Bolivar Missouri
United States Mercy Hematology & Oncology Associates Canton Ohio
United States University of Virginia Cancer Center Charlottesville Virginia
United States Oncology Hematology Care - Blue Ash Cincinnati Ohio
United States Beacon Cancer Care Coeur d'Alene Idaho
United States John B. Amos Cancer Center Research Columbus Georgia
United States The Ohio State University College of Medicine Columbus Ohio
United States The Oncology Institute of Hope and Innovation - Corona Corona California
United States Pontchartrain Cancer Center - Covington Office Covington Louisiana
United States Texas Oncology - Baylor Charles A. Sammons Cancer Center Dallas Texas
United States Texas Oncology - Dallas Presbyterian Hospital Dallas Texas
United States Texas Oncology - Methodist Dallas Cancer Center Dallas Texas
United States Commonwealth Cancer Center Danville Kentucky
United States Texas Oncology - Denton South Denton Texas
United States Barbara Ann Karmanos Cancer Institute Detroit Michigan
United States Henry Ford Hospital Detroit Michigan
United States Evanston Hospital Evanston Illinois
United States Providence Regional Center Partnership Everett Washington
United States Summit Medical Group - Florham Park Campus Florham Park New Jersey
United States Michael and Dianne Bienes Comprehensive Cancer Center Fort Lauderdale Florida
United States Florida Cancer Specialists & Research Institute Fort Myers Florida
United States Fort Wayne Medical Oncology and Hematology - Fort Wayne South Office Fort Wayne Indiana
United States The Center for Cancer & Blood Disorders - Fort Worth Fort Worth Texas
United States Hematology Oncology Associates of Fredericksburg Fredericksburg Virginia
United States Saint Joseph Heritage Healthcare - Virginia K. Crosson Cancer Center Fullerton California
United States Palo Verde Cancer Specialists - Glendale Glendale Arizona
United States Goshen Center for Cancer Care Goshen Indiana
United States Sisters of Charity of Leavenworth Health St. Mary's Grand Junction Colorado
United States Comprehensive Cancer Centers of Nevada Henderson Nevada
United States Memorial Regional Hospital Hollywood Florida
United States Straub Medical Center Honolulu Hawaii
United States USOR - Consultants in Medical Oncology and Hematology PC - Abington Hematology/Oncology Associates Horsham Pennsylvania
United States Millennium Physicians - North Houston Houston Texas
United States Texas Oncology - Houston Willowbrook Houston Texas
United States Clearview Cancer Institute Huntsville Alabama
United States Franciscan Health Indianapolis Indianapolis Indiana
United States Jackson Oncology Associates Jackson Mississippi
United States Broome Oncology Johnson City New York
United States NEA Baptist Fowler Family Center for Cancer Care Jonesboro Arkansas
United States Saint Bernards Medical Center Jonesboro Arkansas
United States Kansas City Care Health Center - Research Medical Campus Kansas City Missouri
United States Good Samaritan Medical Center Lafayette Colorado
United States Indiana University Health Arnett Cancer Care Lafayette Indiana
United States Monter Cancer Center Lake Success New York
United States Watson Clinic Cancer & Research Center Lakeland Florida
United States Regional Cancer Care Associates - Little Silver Little Silver New Jersey
United States Pacific Shores Medical Group Long Beach California
United States Cancer and Blood Specialty Clinic Los Alamitos California
United States Los Angeles Hematology Oncology Medical Group Los Angeles California
United States University of California Los Angeles - Jonsson Comprehensive Cancer Center Los Angeles California
United States Norton Cancer Institute - Broadway Louisville Kentucky
United States University Wisconsin Carbone Cancer Center Madison Wisconsin
United States Northwest Georgia Oncology Centers - Marietta Marietta Georgia
United States Tricounty Hematology and Oncology- Massillon Massillon Ohio
United States Texas Oncology - McKinney McKinney Texas
United States Baptist Cancer Center - Memphis Memphis Tennessee
United States Mount Sinai Medical Center Miami Beach Florida
United States Froedtert Hospital - Medical College of Wisconsin Milwaukee Wisconsin
United States SCRI - Tennessee Oncology - Nashville - Centennial Nashville Tennessee
United States Hoag Memorial Hospital Presbyterian Newport Beach California
United States Illinois Cancer Specialists - Niles Niles Illinois
United States Eastern Connecticut Hematology and Oncology Associates Norwich Connecticut
United States Florida Cancer Affiliates - Ocala - Main Ocala Florida
United States Mercy Clinic Oncology and Hematology - Coletta Oklahoma City Oklahoma
United States Methodist Hospital - Omaha Omaha Nebraska
United States Cancer Institute of Florida - Orlando Orlando Florida
United States Fox Chase Cancer Center Philadelphia Pennsylvania
United States BRCR Medical Center Inc Plantation Florida
United States New York Cancer & Blood Specialists Port Jefferson Station New York
United States Oregon Health and Science University Knight Cancer Institute Portland Oregon
United States Providence Cancer Institute Franz Clinic Portland Oregon
United States Redlands Hematology Oncology Redlands California
United States Virginia Cancer Institute - Reynolds Crossing Richmond Virginia
United States Maryland Oncology Hematology - Rockville Aquilino Cancer Center Rockville Maryland
United States Park Nicollet - Frauenshuh Cancer Center Saint Louis Park Minnesota
United States Texas Oncology - San Antonio San Antonio Texas
United States University of California San Francisco San Francisco California
United States California Cancer Associates for Research and Excellence - San Marcos San Marcos California
United States SCRI - Florida Cancer Specialists - North Region Research Office Sarasota Florida
United States New England Cancer Specialists Scarborough Maine
United States Seattle Cancer Care Alliance Seattle Washington
United States Texas Oncology - Sherman Sherman Texas
United States Orchard Healthcare Research Inc. Skokie Illinois
United States Cancer Care Northwest - North Spokane Spokane Washington
United States Highlands Oncology Group - Springdale Springdale Arkansas
United States Stony Brook University Cancer Center Stony Brook New York
United States Texas Oncology - Sugar Land Sugar Land Texas
United States MultiCare Institute for Research & Innovation Tacoma Washington
United States Northwest Medical Specialties, PLLC Tacoma Washington
United States SCRI - Florida Cancer Specialists - Panhandle Research Office Tallahassee Florida
United States The Oncology Institute of Hope and Innovation - Thousand Oaks Thousand Oaks California
United States Toledo Clinic Cancer Center Toledo Ohio
United States Torrance Memorial Physician Network - Cancer Care and Infusion Center Torrance California
United States The Oncology Institute of Hope and Innovation - Tucson Tucson Arizona
United States Texas Oncology - Tyler Tyler Texas
United States Northwest Cancer Specialists Vancouver Washington
United States Brian J. LeBerthon M.D. West Covina California
United States SCRI - Florida Cancer Specialists - West Palm Beach West Palm Beach Florida
United States The Richard and Annette Bloch Cancer Care Pavilion and Westwood Medical Pavilion Westwood Kansas
United States The Oncology Institute of Hope and Innovation - Whittier Whittier California
United States Cancer Center of Kansas Wichita Kansas
United States Yuma Regional Medical Center Yuma Arizona

Sponsors (2)

Lead Sponsor Collaborator
Mirati Therapeutics Inc. Bristol-Myers Squibb

Countries where clinical trial is conducted

United States,  Belgium,  Canada,  France,  Germany,  Hungary,  Israel,  Italy,  Netherlands,  Spain,  Switzerland,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Overall Survival (OS) OS is defined as time from date of randomization to date of death due to any cause 36 Months
Secondary Adverse Events (AEs) Frequency of patients experiencing treatment-emergent AEs 36 Months
Secondary Objective Response Rate (ORR) ORR defined as complete response (CR) or partial response (PR) per RECIST version 1.1 recorded from randomization until disease progression or start of new anti-cancer therapy 36 Months
Secondary Progression-Free Survival (PFS) PFS is defined as the time from randomization to the date of the first documentation of objective disease progression or death due to any cause 36 months